Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Icotinib (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 25 Sep 2012 New trial record
- 20 Sep 2012 Biomarkers information updated